Immunovia AB (publ) IMMVF Stock
0.15 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Diagnostics & Research
COUNTRY
United States
Exchange
Other OTC
Market Cap
7.68M USD
LOW - HIGH [24H]
0.15
-
0.15 USD
VOLUME [24H]
325 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.97 USD
Immunovia AB (publ) Price Chart
Immunovia AB (publ) IMMVF Financial and Trading Overview
| Immunovia AB (publ) stock price | 0.15 USD |
| Previous Close | 3.16 USD |
| Open | 3.1 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 3.16 - 3.16 USD |
| 52 Week Range | 2.96 - 3.18 USD |
| Volume | 5 USD |
| Avg. Volume | 0 USD |
| Market Cap | 142.88M USD |
| Beta (5Y Monthly) | 1.560919 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.97 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IMMVF Valuation Measures
| Enterprise Value | 71.4M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Immunovia AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.560919 |
| 52-Week Change | 0.15% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.18 USD |
| 52 Week Low | 2.96 USD |
| 50-Day Moving Average | 3.16 USD |
| 200-Day Moving Average | 3.16 USD |
IMMVF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 45.29M |
| Float | 19.32M |
| Short Ratio | N/A |
| % Held by Insiders | 15.65% |
| % Held by Institutions | 1.56% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | -169.58% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -34.33% |
| Return on Equity (ttm) | -60.42% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 185.69% |
| Gross Profit (ttm) | -3066000 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.64 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 18.5 USD |
| Current Ratio (mrq) | 2.667 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Immunovia AB (publ)
| Country | United States |
| State | N/A |
| City | Lund |
| Address | Medicon Village |
| ZIP | 223 63 |
| Phone | 46 4 62 75 60 00 |
| Website | https://www.immunovia.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 51 |
Immunovia AB (publ), a diagnostic company, develops and commercializes blood-based diagnostics for cancer in Sweden and internationally. It offers IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Q&A For Immunovia AB (publ) Stock
What is a current IMMVF stock price?
Immunovia AB (publ) IMMVF stock price today per share is 0.15 USD.
How to purchase Immunovia AB (publ) stock?
You can buy IMMVF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Immunovia AB (publ)?
The stock symbol or ticker of Immunovia AB (publ) is IMMVF.
Which industry does the Immunovia AB (publ) company belong to?
The Immunovia AB (publ) industry is Diagnostics & Research.
How many shares does Immunovia AB (publ) have in circulation?
The max supply of Immunovia AB (publ) shares is 51.21M.
What is Immunovia AB (publ) Price to Earnings Ratio (PE Ratio)?
Immunovia AB (publ) PE Ratio is now.
What was Immunovia AB (publ) earnings per share over the trailing 12 months (TTM)?
Immunovia AB (publ) EPS is -0.97 USD over the trailing 12 months.
Which sector does the Immunovia AB (publ) company belong to?
The Immunovia AB (publ) sector is Healthcare.